← Open Payments lookup

GUY BRANNON: Open Payments

NPI 1164481875 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,745 in 95 payments from 12 companies in 2025. Trend: 2023 $1,668 · 2024 $1,597 · 2025 $1,745

Food & beverage: $1,741Education: $5
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.19$274
ABBVIE INC.11$208
Otsuka America Pharmaceutical, Inc.10$195
Janssen Pharmaceuticals, Inc10$186
E.R. Squibb & Sons, L.L.C.10$158
Lundbeck LLC6$128
Alkermes, Inc.7$128
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$125
LivaNova USA, Inc.3$118
Teva Pharmaceuticals USA, Inc.5$99

Products named: INGREZZA, REXULTI, VRAYLAR, INVEGA SUSTENNA, COBENFY, ARISTADA, CAPLYTA, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR.

Industry payments across LA — which companies pay providers there.